Spotlight On... Vet drugmaker Chanelle Group putting €70M into Ireland plant; India close on new API import rules; Indonesia changes API plant ownership rule; and more...

Ireland-based Chanelle Group, a maker of veterinary generic drugs, has big plans for its manufacturing facility in Loughrea County in Galway. It will invest €70 million ($78 million) to double capacity and will add 175 jobs when it is complete, bringing the company's employment to more than 550 in West Ireland. Construction on the 30,000-square-foot expansion is slated to begin in March, the company said in an announcement. Michael Burke, founder and managing director of Chanelle Group, said the company will also be expanding into new markets, including the U.S. and Central and South America. Release

> India expects within the month to have a new policy that would reduce the amount of APIs it is importing, particularly from China. Story

> China is working to do a better job of overseeing manufacturing quality as one point in a multifaceted healthcare reform program. Report

> Indonesia is dropping its 85% limit for foreign companies investing in API producers in the country in an effort to attract more local production. Report

Suggested Articles

Eli Lilly is investing $400 million in its Indianapolis site to expand production of insulin and other diabetes meds, and add 100 jobs.

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.